Whole-Body Vibration Therapy in the Gait of Children With Cerebral Palsy
Launched by UNIVERSIDAD DE ALMERIA · Mar 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how whole-body vibration therapy may help improve walking (gait) in children with cerebral palsy, a neurological condition that affects movement and coordination. The trial aims to understand how this type of therapy impacts the children's ability to walk and their overall development.
Children between the ages of 2 and 11 who have been diagnosed with cerebral palsy and are classified as having mild to moderate motor difficulties may be eligible to participate. To join, parents or guardians must provide consent for their child to take part, and they can choose to withdraw from the study at any time if they wish. During the trial, participants will engage in vibration therapy, which involves standing on a special platform that gently vibrates. This therapy is thought to stimulate muscles and improve movement. It's important to note that children with certain conditions, like epilepsy or serious circulation problems, cannot participate. This study is being conducted in collaboration with a local child development center, making it a great opportunity for families seeking new ways to support their child's mobility.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of neurological developmental disorder: Cerebral Palsy. (According to DSM-V)
- • Age between 2 to 11 years.
- • GMFCS I and II.
- • Assessed and/or intervened in or from centers, institutions, etc. who collaborate with the University of Almería or participate in them. Specifically from the "Interactúa" Child Development and Early Care Center.
- • The subject, father/mother/legal guardian of each subject, prior to inclusion in the study, must have signed the informed consent for the participation of himself or his/her child in it, leaving a record that it could be abandoned if at any time they deem it appropriate and without having to justify it.
- Exclusion Criteria:
- • Diagnosis of Epilepsy.
- • Serious blood circulation problems.
- • Recent operations.
- • Prosthetics.
- • Start of another type of therapy different from the current one.
- • Not having indication for Physiotherapy.
About Universidad De Almeria
The Universidad de Almería is a prominent academic institution in Spain, dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research endeavors aimed at improving patient care and outcomes. With a commitment to ethical standards and rigorous scientific methodology, the Universidad de Almería collaborates with healthcare professionals and researchers to conduct clinical trials that contribute to the development of new therapeutic interventions and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Almería, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported